112 related articles for article (PubMed ID: 2420968)
21. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
22. [Effect of bradkinin-potentiating snake venom peptides and C-terminal pentapeptide fragment of bradkinin on carboxypeptidase N and kiniase activities of human blood serum].
Paskhina TS; Traleznikova SS; Egorovoa TL; Morozova NA
Biokhimiia; 1975; 40(4):844-53. PubMed ID: 173428
[TBL] [Abstract][Full Text] [Related]
23. The effect of peptidase inhibitors on bradykinin-induced bronchoconstriction in guinea-pigs in vivo.
Ichinose M; Barnes PJ
Br J Pharmacol; 1990 Sep; 101(1):77-80. PubMed ID: 2282470
[TBL] [Abstract][Full Text] [Related]
24. Interaction between arterial pressure and vasoactive hormones in the release of renal kallikrein.
Mills IH; Newport PA; Obika LF
Adv Exp Med Biol; 1979; 120B():561-70. PubMed ID: 517250
[No Abstract] [Full Text] [Related]
25. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
Takata Y; Di Nicolantonio R; Hutchinson JS
Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
[TBL] [Abstract][Full Text] [Related]
26. Effect of converting enzyme inhibition with captopril on baroreflex sensitivity.
Fenoy FJ; Ubeda M; Hernández I; Quesada T
Rev Esp Fisiol; 1988 Mar; 44(1):1-6. PubMed ID: 3051194
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
28. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between the kininase and angiotensin-converting lung functions in rabbits with cerebroischemic and renovascular hypertension].
Karpitskiĭ VV; Gomazkov OA
Biull Eksp Biol Med; 1982 Jan; 93(1):24-6. PubMed ID: 6279206
[No Abstract] [Full Text] [Related]
30. [Attenuation of the vasopressor effect of angiotensin II, vasopressin and alpha 1-adrenergic stimulation by bradykinin].
Aubert JF; Waeber B; Nussberger J; Vavrek R; Stewart JM; Brunner HR
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):832-4. PubMed ID: 3116981
[TBL] [Abstract][Full Text] [Related]
31. [Kininase from the Latrodectus tredecimguttatus venom. Characteristics of the enzyme as a thiol endopeptidase hydrolyzing the -Pro7-Phe8- bond of bradykinin].
Makevnina LG; Golubenko Z; Akhunov A; Paskhina TS
Biokhimiia; 1990 Aug; 55(8):1481-90. PubMed ID: 2288987
[TBL] [Abstract][Full Text] [Related]
32. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N.
Plummer TH; Ryan TJ
Biochem Biophys Res Commun; 1981 Jan; 98(2):448-54. PubMed ID: 7225104
[No Abstract] [Full Text] [Related]
33. Measurement of des-Phe8-Arg9-bradykinin by enzyme-immunoassay--a useful parameter of plasma kinin release.
Majima M; Ueno A; Sunahara N; Katori M
Adv Exp Med Biol; 1989; 247B():331-5. PubMed ID: 2692413
[No Abstract] [Full Text] [Related]
34. Potentiating mechanism of bradykinin action on smooth muscle by sulfhydryl compounds.
Iso T; Nishimura K; Oya M; Iwao J
Eur J Pharmacol; 1979 Mar; 54(3):303-5. PubMed ID: 428428
[TBL] [Abstract][Full Text] [Related]
35. Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins.
Tan F; Jackman H; Skidgel RA; Zsigmond EK; Erdös EG
Anesthesiology; 1989 Feb; 70(2):267-75. PubMed ID: 2913861
[TBL] [Abstract][Full Text] [Related]
36. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
Huey R; Bloor CM; Kawahara MS; Hugli TE
Am J Pathol; 1983 Jul; 112(1):48-60. PubMed ID: 6859228
[TBL] [Abstract][Full Text] [Related]
37. [Phe8 psi(CH2-NH)Arg9]bradykinin, a B2 receptor selective agonist which is not broken down by either kininase I or kininase II.
Drapeau G; Rhaleb NE; Dion S; Jukic D; Regoli D
Eur J Pharmacol; 1988 Oct; 155(1-2):193-5. PubMed ID: 2907489
[No Abstract] [Full Text] [Related]
38. [Relationship between the kininase- and angiotensin- converting activity under normal conditions and in experimental myocardial infarct].
Gomazkov OA; Shimkovich MV; Chernukh AM
Kardiologiia; 1977 Jan; 17(1):103-8. PubMed ID: 192936
[TBL] [Abstract][Full Text] [Related]
39. Kininase inhibition by glucagon.
Olsen UB
Acta Endocrinol (Copenh); 1978 Mar; 87(3):552-6. PubMed ID: 580144
[TBL] [Abstract][Full Text] [Related]
40. Bradykinin metabolism pathway in the rat pulmonary circulation.
Pesquero JB; Jubilut GN; Lindsey CJ; Paiva AC
J Hypertens; 1992 Dec; 10(12):1471-8. PubMed ID: 1363432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
